S100A9 and cutaneous squamous cell carcinoma: Additionally, FABP5 plays a significant role in skin tumors; suppressing FABP5 or S100A9 expression impedes the proliferation and migration of cutaneous squamous cell carcinoma cells via the NF-κB pathway (88).